Immunogenicity of recombinant human proteins: causes and consequencesSCHELLEKENS, Huub; CASADEVALL, Nicole.Journal of neurology. Supplement. 2004, Vol 251, Num 2, pp 4-9, issn 0939-1517, 6 p.Article

«JAK» a dit : c'est un syndrome myéloprolifératif = JAK2 V617F mutation and the myeloproliferative disordersVAINCHENKER, William; CASADEVALL, Nicole.Hématologie (Montrouge). 2006, Vol 12, Num 1, pp 3-7, issn 1264-7527, 5 p.Article

Toute thrombose splanchnique doit faire rechercher un syndrome myéloprolifératif fruste : Syndromes myéloprolifératifs = Any splanchnic vein thrombosis must make look for a forme fruste of myeloproliferative disorder : Myeloproliferative disordersCASADEVALL, Nicole; VALLA, Dominique.La Revue du praticien (Paris). 2005, Vol 55, Num 15, pp 1669-1670, issn 0035-2640, 2 p.Article

Pure red cell aplasia and anti-erythropoietin antibodies in patients treated with epoetinCASADEVALL, Nicole.Nephrology, dialysis, transplantation (Print). 2003, Vol 18, pp viii37-viii41, issn 0931-0509, SUP8Conference Paper

Anticorps anti-érythropoïétine chez des patients insuffisants rénaux traités par l'hormone recombinante = Development of anti-erythropoietin antibodies in patients with renal failure traited by the hormoneCASADEVALL, Nicole; MAYEUX, Patrick.MS. Médecine sciences. 2002, Vol 18, Num 5, pp 542-543, issn 0767-0974Article

Place des facteurs de croissance dans le traitement des syndromes myélodysplasiques : Mini symposium sur les myélodysplasies = Hematopoietic growth factors in the treatment of the myelodysplastic syndromes : Mini symposium on the myelodysplastiesUGO, Valérie; CASADEVALL, Nicole.Pathologie et biologie. 2002, Vol 50, Num 4, pp 268-274, issn 0369-8114Article

Pure red-cell aplasia due to anti-erythropoietin antibodiesECKARDT, Kai-Uwe; CASADEVALL, Nicole.Nephrology, dialysis, transplantation (Print). 2003, Vol 18, Num 5, pp 865-869, issn 0931-0509, 5 p.Article

Antibodies against rHuEPO: native and recombinantCASADEVALL, Nicole.Nephrology, dialysis, transplantation (Print). 2002, Vol 17, pp 42-47, issn 0931-0509, SUP5Conference Paper

What is antibody-mediated pure red cell aplasia (PRCA)?CASADEVALL, Nicole.Nephrology, dialysis, transplantation (Print). 2005, Vol 20, pp iv3-iv8, issn 0931-0509, SUP4Conference Paper

Erythroblastopénie et autres anémies centrales auto-immunes : Cytopénies sanguines d'origine immunitaire = Autoimmu disorders of erythropoiesisCASADEVALL, Nicole; CROISILLE, Laure.La Revue du praticien (Paris). 2001, Vol 51, Num 14, pp 1547-1551, issn 0035-2640Article

Diagnostic et traitement des érythroblastopénies induites par les agents stimulant l'érythropoïèse = Diagnosis and treatment of pure red-cell aplasia induced by erythropoiesis stimulating agentsROSSERT, Jérome; CASADEVALL, Nicole.Néphrologie & thérapeutique. 2006, Vol 2, issn 1769-7255, S283-S286, SUP4Article

Anti-erythropoietin antibodies and pure red cell aplasiaROSSERT, Jerome; CASADEVALL, Nicole; ECKARDT, Kai-Uwe et al.Journal of the American Society of Nephrology. 2004, Vol 15, Num 2, pp 398-406, issn 1046-6673, 9 p.Article

Autoimmune disorders of erythropoiesisCROISILLE, Laure; TCHERNIA, Gil; CASADEVALL, Nicole et al.Current opinion in hematology. 2001, Vol 8, Num 2, pp 68-73, issn 1065-6251Article

Place de l'érythropoïétine dans la correction de l'anémie des myélodysplasies = Use of erythropoietin in the treatment of anemia in myelodysplastic syndromesCASADEVALL, Nicole.Hématologie (Montrouge). 2001, Vol AOU, pp 12-16, issn 1264-7527, NSConference Paper

Molecular aspects of myeloproliferative neoplasms : PIH: Molecular mechanism, diagnosis, and treatment for myeloproliferative neoplasmsDELHOMMEAU, François; JEZIOROWSKA, Dorota; MARZAC, Christophe et al.International journal of hematology. 2010, Vol 91, Num 2, pp 165-173, issn 0925-5710, 9 p.Article

Antibody-mediated pure red cell aplasia (PRCA) treatment and re-treatment : multiple optionsROSSERT, Jérome; MACDOUGALL, Iain; CASADEVALL, Nicole et al.Nephrology, dialysis, transplantation (Print). 2005, Vol 20, pp iv23-iv26, issn 0931-0509, SUP4Conference Paper

Physiopathologie des anémies inflammatoires = Physiopathology of inflammatory anemiaCASADEVALL, Nicole.Hématologie (Montrouge). 2002, Vol 8, Num mars, pp 13-16, issn 1264-7527, NSConference Paper

Successful re-challenge with darbepoetin in a patient with rHu-EPO-induced pure red cell aplasia refractory to immunosuppressive drugsVIRON, Béatrice; DUPUY, Claire-Antoinette; KOLTA, Amir et al.Nephrology, dialysis, transplantation (Print). 2008, Vol 23, Num 7, pp 2416-2418, issn 0931-0509, 3 p.Article

Evaluation of methods to detect and characterize antibodies against recombinant human erythropoietinSWANSON, Steven J; FERBAS, John; MAYEUX, Patrick et al.Nephron. 2004, Vol 96, Num 3, pp c88-c95, issn 0028-2766Article

Epoetin-induced autoimmune pure red cell aplasiaCASADEVALL, Nicole; ECKARDT, Kai-Uwe; ROSSERT, Jérome et al.Journal of the American Society of Nephrology. 2005, Vol 16, pp S67-S69, issn 1046-6673, SUP1Conference Paper

Early high-dose erythropoietin therapy and hypothermia after out-of-hospital cardiac arrest : A matched control studyCARIOU, Alain; CLAESSENS, Yann-Erick; PENE, Frederic et al.Resuscitation. 2008, Vol 76, Num 3, pp 397-404, issn 0300-9572, 8 p.Article

The impact of JAK2 and MPL mutations on diagnosis and prognosis of splanchnic vein thrombosis : a report on 241 cases. CommentaryNIESWANDT, Bernhard; KILADJIAN, Jean-Jacques; MURAD, Sarwa Darwish et al.Blood. 2008, Vol 111, Num 10, issn 0006-4971, 4835, 4922-4929 [9 p.]Article

Arsenic trioxide in patients with myelodysplastic syndromes : A phase II multicenter studyVEY, Norbert; BOSLY, Andre; CASADEVALL, Nicole et al.Journal of clinical oncology. 2006, Vol 24, Num 16, pp 2465-2471, issn 0732-183X, 7 p.Article

Relevance of the criteria commonly used to diagnose myeloproliferative disorder in patients with splanchnic vein thrombosisCHAIT, Yasmine; CONDAT, Bertrand; CASADEVALL, Nicole et al.British journal of haematology. 2005, Vol 129, Num 4, pp 553-560, issn 0007-1048, 8 p.Article

Value of in vitro models for the assessment of drug-induced haematotoxicityGOLDFAIN-BLANC, Francoise; WATTRELOS, Olivier; CASADEVALL, Nicole et al.Thérapie (Paris). 2004, Vol 59, Num 6, pp 607-610, issn 0040-5957, 4 p.Article